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INTER PARTES REVIEW:  
AN EARLY LOOK AT THE NUMBERS 
 
Brian J. Love* 
Shawn Ambwani** 
 
81 University of Chicago Law Review Dialogue (forthcoming Oct. 2014) 
 
In the roughly two years since inter partes review replaced inter partes 
reexamination, petitioners have filed almost two-thousand requests for the 
Patent Trial and Appeal Board to review the validity of issued U.S. 
patents.1  As partial data on inter partes review (IPR) has trickled out via 
the blogosphere,2 interest from patent practitioners and judges has grown 
to a fever (and sometimes fevered) pitch.3  To date, however, no 
commentator has collected a comprehensive set of statistics on IPR.  
                                         
* Assistant Professor of Law and Co-Director of the High Tech Law Institute,  Santa 
Clara University School of Law.   
** Chief Operating Officer,  Unified Patents,  Inc.,  and Chairman, Licensing 
Executives Society, Inc.,  High Tech Sector.   We thank participants at the 2014 I.P. 
Scholars Conference at U.C. Berkeley School of Law.  Jacob Vigil and Alexander Shei 
provided excellent research assistance. 
1 The Patent Trial and Appeal Board began accepting petitions for inter partes review 
on September 16, 2012.  See Leahy-Smith America Invents Act,  Pub. L. No. 112-29, 
125 Stat.  284, 304 (2011) (stating that the sections pertaining to inter partes review 
“shall take effect upon the expiration of the 1-year period beginning on the date of the 
enactment”).     
2 See, e.g. ,  Post of Scott A. McKeown to Patents Post-Grant Blog, PTAB Institution 
Rate Dips Into 60% Range,  http://www.patentspostgrant.com/ptab-institution-rate-dips-
into-60-range (July 21, 2014); Post of Michelle Carniaux & Michael E. Sander to the 
Inter Partes Review Blog, Instituted Patent Claims Survive in About One Third of All 
IPR Trials,  http://interpartesreviewblog.com/instituted-patent-claims-survive-one-third-
ipr-trials/#more-662 (Aug. 13, 2014); Merchant & Gould,  Inter Partes Review 
Procedure Statistics,  http://www.merchantgould.com/OurPractice_PostGrant_IPR_
Statistics.aspx (last updated Oct.  1,  2013).  
3 See, e.g. ,  Tony Dutra,  Rader Regrets CLS Bank Impasse, Comments on Latest 
Patent Reform Bill,  Bloomberg BNA, Oct.  29, 2013, http://www.bna.com/rader-regrets-
cls-n17179879684/ (“[T]he PTAB . .  .  [is] 300 administrative patent judges ‘acting as 
death squads, killing property rights. ’” (quoting Randall Rader, then Chief Judge of the 
U.S. Court of Appeal for the Federal Circuit)); Post of Robert Greene Sterne & Gene 
Quinn to the IPWatchdog Blog, PTAB Death Squads: Are All Commercially Viable 
Patents Invalid?, http://www.ipwatchdog.com/2014/03/24/ptab-death-squads-are-all-
commercially-viable-patents-invalid/id= 48642/ (March 2014 1:42 PM) (“Ultimately, if 
the PTAB continues on this path, the raison d’etre of the Patent Office and the entire 
patent system will be called into question .  .  .  .”).  
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Moreover, what little data currently exists focuses on overall institution 
and invalidation rates—data that, alone, gives us little idea whether IPR is 
thus far accomplishing its original goal of serving as a quick, efficient 
alternative to defending patent suits filed in federal court, particularly 
those initiated by non-practicing entities (NPEs).4 
This Essay aims to fill both gaps by reporting the findings of an 
empirical study tracking the outcome of IPRs and their impact on co-
pending litigation.  As described in greater detail below, we find that: 
 Petitions for IPR are instituted for at least one challenged claim 84 
percent of the time; 
 Among instituted IPRs, all challenged claims are instituted 74 
percent of the time; 
 Among IPRs that reach a final decision on the merits, all instituted 
claims are invalidated or disclaimed more than 77 percent of the 
time; 
 IPRs challenging NPE-owned patents are more likely to be 
instituted and, on average, are instituted for a larger share of 
challenged claims, but have their claims invalidated at a lower rate; 
 Litigation proceeding in parallel with an instituted IPR is stayed 
about 82 percent of the time. 
Though it is too early to draw sweeping conclusions from these 
statistics, they suggest that inter partes review promises to be considerably 
more potent than inter partes reexamination and, moreover, to have a 
substantial impact on co-pending patent litigation, particularly suits filed 
by NPEs. 
   
BACKGROUND 
 
Prior to the America Invents Act, parties could administratively 
challenge issued patents at the U.S. Patent and Trademark Office via one 
                                         
4 H.R. Rep. No. 112-98, pt.  1,  at 48 (2011) (referring to the post-grant review 
proceedings created by the AIA as “quick and cost effective alternatives to litigation”); 
see also Alston & Bird, LLP, Inter Partes Review – One Year Later 1 (Sept.  17, 2013) 
(“IPR was designed to be a cost-effective alternative to litigation. In fact,  its legislative 
history states that the IPR process ‘will allow invalid patents that were mistakenly issued 
by the USPTO to be fixed early in their life,  before they disrupt an entire industry or 
result in expensive litigation.’” (quoting 157 Cong. Rec. S1326 (daily ed. Mar. 7, 2011) 
(statement of Sen. Sessions))),  available at http://www.alston.com/
files/publication/ba36e481-8956-4318-a846-b1547e87b773/presentation/publication
attachment/651fa1eb-2994-427d-863e-b9275e537113/13-691-inter-partes-review-one-
year-laterpdf.pdf.  
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of two forms of reexamination: ex parte reexamination, which proceeded 
essentially as an extension of the patent’s original ex parte examination, 
and inter partes reexamination, which allowed the challenger to take an 
adversarial role in the process in exchange for a waiver of its ability to re-
argue validity later in court.5 
Though originally developed to serve as a cost-effective alternative to 
full-blown litigation,6 reexaminations rarely did so.  To the contrary, 
reexamination developed a well-deserved reputation for lengthy delays, a 
lack of decisive results, and a permissiveness for claim amendments that 
led some in the patent bar to view reexamination more as a vehicle for 
patentees to strengthen their patent rights post hoc than as a tool for 
possible infringers to quickly and cheaply eliminate invalid claims without 
resorting to litigation.7 
Spurred by (at least a perception of) widespread litigation abuse, 
Congress passed the America Invents Act (AIA) in 2011.8  Among other 
                                         
5 See, e.g. ,  RatnerPrestia,  Ex Parte versus Inter Partes Reexamination, http://
www.rppostgrant.com/ComparisonCharts/index.html (last visited Aug. 17, 2014) 
(highlighting the similarities and differences between ex parte and inter partes 
reexamination).  
6 See 145 Cong. Rec. H6929, H6944 (daily ed. Aug. 3, 1999) (statement of Rep. 
Dana Rohrabacher) (“This title was an attempt . . .  to further encourage potential 
litigants to use the PTO as a [sic] avenue to resolve patentability issues without expanding 
the process into one resembling courtroom proceedings.”).  
7Inter partes reexamination took 3 years on average, after which challenged patents 
survived 69% of the time, generally with new claims added.  Patent & Trademark Off. , 
Inter Parte Reexamination Filing Data (Sept.  30, 2013), 
http://www.uspto.gov/patents/stats/inter_parte_historical_stats_roll_up_EOY2013.pdf  
[hereinafter PTO IPX Data].   As a result,  many patent lawyers viewed reexamination as 
more likely to strengthen a patent than to weaken it.   See,  e.g. ,  Kyle J.  Trout & Thomas 
C. Stuart,  Managing Risk in The Age Of The Patent Troll (Part 2),  WESTLAW J.  INTELL.  
PROP. ,  Feb. 19, 2014, at 1 (“[R]e-examination proves to be a double-edged sword that 
[often] necessitates taking a license on less favorable terms against .  .  .  strengthened 
reissued claims .  .  .  .”).   As evidence of this,  consider that many litigation-minded 
patentees voluntarily subject their patents to ex parte reexamination.  See, e.g. ,  Changes 
To Implement the Supplemental Examination Provisions of the Leahy-Smith America 
Invents Act and To Revise Reexamination Fees; Final Rule,  77 Fed. Reg. 48827 (2012) 
(“[T]he Office estimates that it receives approximately 110 requests for ex parte 
reexamination filed by patent owners annually.”).  
8 Leahy-Smith America Invents Act,  Pub. L. No. 112-29, 125 Stat.  284 (2011).  On 
the motivations behind passage of the AIA, particularly the modification to administrative 
review, see, e.g.,  Q. Todd Dickinson, Exec. Dir. ,  Am. Intell.  Prop. L. Assoc., 
Testimony before the U. S. Senate Judiciary Committee hearing on Protecting Small 
Businesses and Promoting Innovation by Limiting Patent Troll Abuse 3-6, 8 (Dec. 17, 
2013) (recounting the debate leading up to the AIA and referring to “the assertion of 
allegedly invalid or overbroad patents” as “the very abuse for which AIA post-grant 
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changes, the AIA replaced the existing regime of inter partes 
reexamination with a modified and renamed inter partes review.9  The 
new legislation raised the bar for granting requests to review a patent, but 
advantaged accepted petitions by mandating a shorter time-to-completion 
and by allowing reviews to take place before the Patent Trial and Appeal 
Board (PTAB) in the first instance, rather than on appeal.10  These 
modifications, legislators hoped, would transform inter partes 
administrative patent challenges into the cheap, efficient litigation 
alternative that inter partes reexamination never proved to be.11 
   
STUDY DESIGN 
 
To test the extent to which Congress has thus far achieved its goals 
with IPR, we collected a variety of data for every petition for inter partes 
review filed between September 16, 2012—the effective date of the 
statutory provision creating IPR—and March 31, 2014.12  During this 
period, challengers filed a total of 979 petitions.13  As shown below in 
Table 1, this tally is roughly half the total number of requests for inter 
partes reexamination filed over the course of the thirteen years prior. 14  As 
of September 30, 2014, the PTAB has received a total of 1,841 petitions 
for IPR, making the rate of inter partes review six times that for inter 
                                                                                                       
procedures were created”), available at http://ipwatchdog.com/blog/dickinson-senate-
testimony-12-17-2013.pdf.  
9 Leahy-Smith America Invents Act,  125 Stat.  at 299-305 (setting forth procedures 
for inter partes review).  
10 See, e.g. ,  Justin A. Henrix & Robert F. Schaffer,  Post Grant Proceedings of the 
AIA Provide New Opportunities and Require Reconsideration of Old Patent Litigation 
Strategies,  MED.  DEVICE,  June 15, 2012 (describing the similarities and differences 
between inter partes review and inter partes reexamination),  available at 
http://www.finnegan.com/resources/articles/articlesdetail.aspx?news= 598696f7-7eba-
4fcb-83b8-2369caa91dd3.  
11 See Dickinson, supra note 8.  
12 Because institution decisions are generally issued close to six months after petitions 
are filed, see infra tbl.3,  this study window includes the vast majority of IPRs that 
received at least a preliminary ruling on their merits by the end of September 2014.   
Moreover, all data presented in this Essay is current as of at least September 30, 2014.  
13 To identify IPRs and access the docket for each, we used Docket Navigator,  
http://www.docketnavigator.com.  In all,  987 petitions for IPR were filed during our 
study window, but we excluded eight petitions challenging design (rather than utility) 
patents.  
14 PTO IPX data,  supra (showing that 1,919 petitions for inter partes reexamination 
were filed between November 29, 1999 and September 11, 2012).  
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partes reexamination.15 
 
Table 1: Quantity of Filings 
 
 Inter Partes 
Reexamination 
Inter Partes  
Review 
Total Petitions: 1919 1841 
Petitions per Month: 12.5 75.1 
 
For each IPR, we collected several pieces of information about the 
petition, the patent, and the parties involved.  First,  we determined 
whether or not the PTAB decided to grant, or “institute,” the IPR 
petition.16  We also determined whether the IPR was still pending or had 
terminated.17  If it was terminated, we noted how and when it terminated.  
As shown below in Table 2, of the 979 petitions that fall within our study 
window, over 40 percent are still pending before the PTAB.  However, 
less than one percent of these petitions are still awaiting an institution 
decision, which confirms that our study window contains the lion share of 
petitions which have, to date, received substantial attention from the 
PTAB.  
 
                                         
15 See Docket Navigator,  http://www.docketnavigator.com. 
16 Leahy-Smith America Invents Act,  125 Stat.  at 300 (setting as the standard for the 
“institution” of inter partes review whether “there is a reasonable likelihood that the 
petitioner would prevail with respect to at least 1 of the claims challenged in the 
petition”).  
17 An IPR can terminate in one of four ways: settlement, a decision not to institute 
the petition, a final written decision from the PTAB, and a request for adverse judgment 
from the patentee. 
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Table 2: IPRs by Outcome Type 
  
Pending: 413 (42.2%) 
  No Institution Decision Yet: 
  Instituted: 
4 
409 
Terminated: 
  Not instituted: 
        On the merits: 
        Untimely or duplicative:  19 
  Settled 
         After Institution: 
         Before Institution: 
   Final Written Decision or 
Req. for Adv. Judgment 
   566 (57.8%) 
191 
           132 
          59 
215 
          128 
          87 
160 
  
Next, we determined whether or not the respondent in the IPR was a 
non-practicing entity.20  Finally, we classified the challenged patent by 
technology21 and determined whether or not it had ever been asserted in 
                                         
19 A party seeking IPR of a patent asserted against it in court must,  by statute,  file a 
petition within one year of being sued.  35 U.S.C. § 315(b) (“An inter partes review may 
not be instituted if the petition requesting the proceeding is filed more than 1 year after 
the date on which the petitioner,  real party in interest,  or privy of the petitioner is served 
with a complaint alleging infringement of the patent.”).   If it fails to seek IPR within that 
one-year window, its petition will be denied as untimely.  The PTAB also may deny a 
petition without reaching its merits on the grounds that it is substantially duplicative of an 
earlier-filed petition.  35 U.S.C. § 325(d) (“In determining whether to institute or order a 
proceeding .  .  . the Director may take into account whether,  and reject the petition or 
request because, the same or substantially the same prior art or arguments previously 
were presented to the Office.”).  
20 Non-practicing entities—patent owners that do not commercialize the patent 
technology and thus, in patent parlance, do not “practice” their patent rights—can take 
many forms, including for-profit firms engaged in patent monetization, individuals, and 
universities.   See, e.g. ,  John R. Allison, et al., Extreme Value or Trolls on Top? The 
Characteristics of the Most-Litigated Patents, 158 U. PA. L. REV. 1, 10-11 (2009) 
(introducing a taxonomy of NPEs that includes – in addition to “patent assertion entities” – 
universities, pre-product startups, and IP-holding subsidiaries of product-producing parent 
companies).   To classify patentees, we combined information obtained from public 
records (namely, court and SEC filings),  the patentees’ own websites,  and business 
directories available from third-parties like Hoover’s,  Inc. and Bloomberg,  L.P. 
21 We categorized patents as one of the following categories: high-tech, bio-pharma, 
other chemical,  medical device,  other mechanical,  and other miscellaneous.  See Brian J.  
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court.22  When we found co-pending litigation between the IPR petitioner 
and respondent, we checked to see whether a motion to stay had been filed 
in the suit and, if so, when it was filed and whether it was successful. 23 
 
FINDINGS 
 
In the paragraphs that follow, we provide statistics on various aspects 
of inter partes review, including the duration of review, institution rates, 
claim validity decisions, and impact on co-pending litigation.  On the 
whole, what we find suggests that inter partes review is considerably more 
powerful than inter partes reexamination and, accordingly, more likely to 
serve its intended purpose as an alternative to full-blown litigation.24 
First,  we find that IPRs have thus far concluded within a relatively 
short period of time.  As shown below in Table 3, among all terminated 
IPRs, the average time to termination was roughly nine months.  Among 
just those IPRs that reached a final determination, the average pendency 
was roughly fifteen months—a duration still considerably shorter than the 
thirty-six month average pendency of inter partes reexamination.25  IPR 
settlements, on average, occurred after seven months, and decisions not to 
institute came, on average, a little under six months after the petition was 
filed. 
 
                                                                                                       
Love, An Empirical Study of Patent Litigation Timing: Could A Patent Term Reduction 
Decimate Trolls Without Harming Innovators?,  161 U.  PA.  L.  REV.  1309, 1329 (2013) 
(describing broad definitions for “software,” “high-tech,” “medical device,” 
“pharmaceutical,” and “biotechnology” patents).   To make the most of limited data,  
below we have consolidated these six classifications into four: high-tech, bio-pharma-
chemical,  medical device-mechanical,  and other.  
22 We determined whether co-pending litigation existed by searching Lex Machina, 
https://lexmachina.com/, for each challenged patent’s number.   
23 We collected data on motions to stay by reviewing the docket sheet available on 
Lex Machina for each co-pending suit.  
24 A direct comparison of statistics for inter partes review and inter partes 
reexamination is included below in Appendix B.  
25 See PTO IPX data,  supra note 7.  
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Table 3: IPR Duration 
  
Duration (days) 
All Terminated IPRs:26 
  Not instituted: 
  Settled 
  Final Written Decision or 
Req. for Adv. Judgment 
270 
169 
221 
456 
  
Next, among IPRs with an institution decision, we find that petitioners 
have thus far been quite successful in convincing the PTAB that 
challenged patents deserve scrutiny.  As shown below in Table 4, among 
IPRs for which an institution decision was made on the petition’s merits, 
the PTAB exercised its discretion to institute review of at least one 
petitioned claim 84 percent of the time.  Though this is lower than the 
historical rate of acceptance for inter partes reexamination—93 percent—it 
is nonetheless unexpectedly close.27  In fact, 22 of the 132 IPRs that were 
not instituted following a decision on the merits were petitions to review 
patents for which another IPR was instituted.  Taking this fact into 
account, less than 14 percent of petitions both sought to challenge a unique 
patent and were not instituted. 
In addition, when PTAB panels have decided to institute inter partes 
review, they have generally concluded that review is warranted for all 
claims challenged in the petition.  Among instituted IPRs, the PTAB 
instituted review of all challenged claims 74 percent of the time and, 
overall, instituted review of more than 88 percent of all challenged claims.   
Moreover, as shown below in Table 5, despite the fact that almost 
two-thirds of IPRs challenge a patent covering a computer- and 
telecommunications-related invention, institution rates are quite consistent 
across technologies.  Appendix A includes more data broken down by 
technology classification. 
 
                                         
26 Excluding IPRs not instituted as untimely or duplicative.  
27 See PTO IPX data,  supra note 7 (reporting that 93% of requests for inter partes 
reexamination were granted by the PTO’s central reexamination unit); Sterne & Quinn, 
supra note 3 (“[N]o one could have predicted .  .  .  how broadly and rapidly the new 
challenges to the patentability of issued U.S. patents would become the standard defense 
tactic in U.S. patent litigation in all areas of technology .  .  .  .  Approximately 80% of the 
claims challenged in petitions are instituted for trial on at least one proposed ground of 
unpatentability .  .  . .”).  
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Table 4: Institution Rates 
  
Petitions with an institution decision: 
     Percent of IPRs with at least 1 claim 
instituted: 
     Percent of IPRs with at least 1 claim 
of a unique patent instituted: 
 
82328 
84.0% 
 
86.3% 
Instituted IPRs: 691 
     Percent of IPRs will all challenged 
claims instituted 
     Percent of challenged claims instituted 
74.0% 
 
88.3% 
 
 
Table 5: By Tech Classification 
 
 High-Tech.  Bio./Pharma./Chem.  Med. Device/Mech.  
Share of All Petitions (Total 
No.)29 
Petitions with an institution 
decision: 
     Percent of IPRs with at 
least 1 claim instituted: 
 
67.1% (657) 
 
551 
 
83.8% 
11.3% (111) 
 
95 
 
83.2% 
 
18.2% (178) 
 
149 
 
82.6% 
 
Instituted IPRs: 462 79 123 
     Percent of IPRs will all 
challenged claims instituted 
     Percent of challenged 
claims instituted 
 
73.4% 
86.5% 
 
74.7% 
90.2% 
 
75.6% 
92.9% 
                                         
28 In six IPRs, the patentee requested an adverse judgment that was granted prior to 
an institution decision.  
29 Compare with PTO IPX Data, supra note 7 (reporting that 45% of inter partes 
reexaminations challenged a patent directed to an “electrical” invention, 15% directed to 
a “chemical” invention, and 25% to a “mechanical” invention).   Some “high-tech” 
patents can be challenged in an IPR or the “Transitional Program for Covered Business 
Method Patents” (CBM review), see Post of Scott A. McKeown to Patents Post-Grant 
Blog, Where Are All the Business Method Patent Challenges?, 
http://www.patentspostgrant.com/where-are-all-the-business-method-patent-challenges 
(Apr.  24, 2013) (discussing the tradeoffs between IPR and CBM review), which like IPR 
was created by the AIA and went into effect in 2012, see AIA § 18.  Thus, were it not 
for the existence of CBM review, the share of patents challenged in IPRs that cover 
“high tech” inventions might be larger still.  
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Narrowing our focus further to IPRs with a decision on claim validity, 
we find that petitioners have also been quite successful before the PTAB 
on the merits of their challenges.  As shown below in Table 6, among 
instituted IPRs with a final decision on the merits, the PTAB eliminated all 
instituted claims almost 78 percent of the time.  Among the same group, 
the PTAB eliminated all claims challenged in the petition 65 percent of the 
time, giving petitioners a complete victory almost two-thirds of the time 
they pursued their IPRs to a final decision.   
Unlike acceptance rates, which are similar for both inter partes review 
and reexamination, the rate at which petitioners succeed on the merits of 
their petitions is markedly different: inter partes reexaminations ended in 
complete victory for the petitioner just 31 percent of the time, less than 
half as often.   Moreover, over 60 percent of inter partes reexaminations 
ended with patentees securing new, amended claims.30  To date, the PTAB 
has granted just a single motion to amend—one that was both unopposed 
and filed by the U.S. itself.31 
 
Table 6: Claim Invalidation Rates 
  
IPRs with decision on merits: 160  
     All instituted claims invalid or 
disclaimed 
     All challenged claims invalid or 
disclaimed 
     Motion to amend granted 
77.5% 
 
65% 
0.62% 
 
Moreover, as rough as IPR has been for patentees to date, we find that 
it has been even tougher on non-practicing patentees.  Table 7 below 
compares petitions challenging patents owned by NPEs and product-
                                         
30 See PTO IPX Data,  supra note 7 (reporting that in 61% of completed inter partes 
reexaminations the challenged patent survived with claim amendments).  
31 International Flavors & Fragrances Inc. v. U.S. Department of Agriculture, No. 
IPR2013-00124, Paper No. 12 (P.T.A.B. May 20, 2014), available at 
http://patentdocs.typepad.com/files/intl-flavors-fragrances-inc.-v.-u.s.a.-ipr2013-00124-
paper-12-p.t.a.b.-may-20-2014.pdf; see also Post of Scott A. McKeown to Patents Post-
Grant Blog, PTAB Grants First Motion to Amend in IPR, 
http://www.patentspostgrant.com/ptab-grants-first-motion-to-amend-in-ipr (May 22, 
2014) (“[T]he motion was unopposed, and was essentially a settlement by amendment 
(challenger was satisfied that new claims were no longer a threat and simply walked 
away) .  .  .  .”).    
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producing companies.  Overall, NPEs are respondents in about 48 percent 
of IPRs, a percentage that roughly matches the share of patent litigation 
filed by NPEs.32  By comparison to challenged patents owned by product-
producing companies, patents owned by NPEs are more likely to be 
challenged in an IPR that is instituted for at least one claim and, on 
average, have a higher percentage of challenged claims instituted.  That 
said, in final decisions, NPE claims are less likely to be invalidated or 
disclaimed,  a finding that roughly cancels out NPEs’ greater per-claim 
institution rate.  Ultimately it would seem that,  in the PTAB’s estimation 
to date, NPE-owned patents are more likely than product-company-owned 
patents to have suspect claims—but suspect claims in both types of patents 
are roughly equally likely to be deemed invalid. 
 
Table 7: NPEs v. Product-Producing Companies 
 
 NPEs Prod. Cos. 
Share of all IPRs: 48.3% 51.7% 
Institution Rate: 88.7%  80%* 
Among instituted IPRs, share instituting all 
challenged claims 
77.0% 71.1% 
Among instituted IPRs, share of claims 
instituted 
90.8%  86.3%* 
Among IPRs with decision on the merits, 
share invalidating all instituted claims 
75.3% 78.1% 
  * p <  0.01 
 
Finally, turning to petitions pending alongside litigation in federal 
court, we find that IPR has thus far proven to be a successful means for 
accused infringers to halt patent suits filed against them.  Table 8 below 
shows data for IPRs with parallel litigation.  Overall, in 80 percent of 
                                         
32 See Sara Jeruss et al. , The America Invents Act 500: Effects of Patent Monetization 
Entities on US Litigation,  11 DUKE L.  & TECH.  REV.  357, 365, 377 (2012) (finding, in a 
study of 100 patent suits filed each year from 2007 to 2011, that the percentage 
attributable to NPEs was roughly 22% in 2007, 27% in 2008, 33% in 2009, 30% in 
2010, and 40% in 2011); Robin Feldman et al. ,  The AIA 500 Expanded: The Effects of 
Patent Monetization Entities,  UCLA J.L.  & TECH. ,  at *9,  *55 (forthcoming) (expanding 
their prior study to find that NPEs filed roughly 59% of patent suits in 2012); 
Christopher A. Cotropia et al. ,  Unpacking Patent Assertion Entities,  MINN.  L.  REV. ,  at 
*25 (forthcoming) (finding that NPEs filed roughly 50% of patent infringement claims in 
2010 and 2012),  available at http://papers.ssrn.com/sol3/papers.cfm?abstract_id=  
2346381. 
12 Inter Partes Review: An Early Look at the Numbers [20-Oct-14 
 
IPRs, the challenged patent was also asserted in litigation between the 
petitioner and respondent. 33  Of patent suits proceeding in parallel with an 
instituted IPR between the same parties, a motion to stay was filed in over 
76 percent.  Overall, these cases were stayed (at least in part) 82 percent 
of the time, though rates varied considerably across districts.  When a 
motion to stay was filed before Markman briefing, cases were stayed even 
more often: close to 84 percent of the time.  Compared to inter partes 
reexamination—for which district courts stayed co-pending litigation less 
than half the time34—petitioning for inter partes review is much more 
likely to result in a stay of litigation and, thereby, save litigation costs and 
reduce a non-practicing patentees’ hold-up power.35 
        
                                         
33 By comparison, almost 76% of inter partes reexaminations challenged a litigated 
patent.   See PTO IPX Data,  supra note 7.  
34 See Eric J.  Rogers,  Ten Years of Inter Partes Patent Reexamination Appeals: An 
Empirical View,  29 SANTA CLARA COMP.  & HIGH TECH.  L.J.  305, 320-21 (2012), 
available at http://digitalcommons.law.scu.edu/cgi/viewcontent.cgi?article= 1559&
context= chtlj (collecting sources and concluding that overall “[m]otions to stay patent 
litigation until the conclusion of a reexam are granted about half of the time” and also 
that rates varied by district with the Northern District of California and the Eastern 
District of Texas granting motions more and less than average, respectively).  
35 Because non-practicing patentees do not sell products of their own, they cannot be 
countersued for infringement and, thus, can impose asymmetrical litigation costs on their 
opponents.   See, e.g. ,  Brian J.  Love, Testimony before the California Assembly Select 
Committee on High Technology informational hearing on Patent Assertion Entities (Oct.  
30, 2013), available at http://papers.ssrn.com/sol3/papers.cfm?abstract_id= 2347138.  
As a result of this cost differential,  NPEs can collect settlements that reflect the cost of 
defense in addition to the value of the patented invention and strength of the patentee’s 
claims.  Id.   If the cost of defense is large enough, patent litigation may still be lucrative 
even when the patent-in-suit is weak and covers technology of little importance.  Id.  
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Table 8: Co-Pending Litigation Stays 
 
 Overall D. Del.  N.D. Cal. E.D. Tex.  C.D. Cal.  
Suits co-pending an instituted IPR 
No. with a motion to stay:36 
No. with a decided motion:37 
% granted:38 
249 
190 
171 
81.9% 
48 
36 
32 
81.2% 
31 
26 
25 
80% 
32 
19 
16 
56.2% 
11 
9 
9 
77.8% 
No. with a decided motion  
filed before claim construction 
briefing 
% granted: 
 
 
140 
83.6% 
 
 
24 
83.3% 
 
 
18 
77.8% 
 
 
13 
69.2% 
 
 
8 
87.5% 
 
In fact, the relative filing dates of IPR petitions and co-pending patent 
suits suggests that administratively challenging a patent may also tend to 
reduce the number of times that patent will be asserted in the future.  
Among co-pending suits enforcing a patent challenged in a terminated 
IPR, roughly 85 percent were filed prior to the IPR petition. 39  In addition, 
over 10 percent of patents challenged in terminated IPRs have, to date, 
never been asserted in court.  In short, IPR does not seem to encourage 
additional patent litigation and, for a substantial number of patents, it 
appears to act as a complete substitute for litigation.   
That said, it is still too early to draw a firm conclusion about IPR’s 
impact on the final outcome of co-pending patent suits between the 
petitioner and respondent.  The vast majority of suits running in parallel 
with an IPR decided on the merits have, themselves, not yet terminated.  
Suits pending with IPRs invalidating claims of the asserted patent largely 
remain stayed pending appeal of the PTAB’s decision to the Federal 
                                         
36 In some suits,  parties filed multiple motions to stay.   This row reports the 
percentage of suits with at least one motion.   
37 In most instances, the motion was not ruled upon because the case settled, or was 
stayed for a reason unrelated to inter partes review, before the court ruled on the motion.   
In a small number of ongoing cases, motions to stay remained pending at the time of 
publication.  
38 This row reports the percentage of suits in which at least one motion to stay was 
granted at least in part.  Compare Wolf Greenfield, IP Strategy: Stays, Presentation to the 
AIPLA Post Grant Committee (June 12, 2014) (copy on file with the authors) (finding, in 
a sample that includes motions to stay filed prior to institution, a grant rate of 60% in the 
District of Delaware, 83% in the Northern District of California,  and 58% in the Eastern 
District of Texas).  
39 In suits between the petitioner and respondent,  94% of co-pending suits were filed 
prior to the IPR petition.  Among suits between the respondent and third-parties,  about 
80% of suits were filed first.  
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Circuit, and suits pending with IPRs that were not instituted are largely 
open and ongoing.40  Thus, the true extent to which IPR simplifies patent 
litigation remains to be seen.  
 
* * * 
 
Though it would be premature to make sweeping claims about inter 
partes review at this time, so far IPR appears to be a powerful shield for 
those accused of patent infringement (and those who anticipate they may 
soon be).  Compared to requests for inter partes reexamination, petitions 
for inter partes review are currently granted at a similar rate, but once 
instituted result in the elimination of every challenged claim about twice as 
often, reach a final decision almost twice as quickly, and make accused 
infringers almost twice as likely to win motions to stay co-pending 
litigation.  In its attempt to create a formidable avenue for administratively 
challenging issued patents, Congress appears to have hit the mark—but 
only time will tell for sure.  
 
                                         
40 Though many final decisions remain pending on appeal,  history suggests that the 
affirmance rate is likely to be high.  See Rogers,  Ten Years of Inter Partes Patent 
Reexamination Appeals: An Empirical View,  supra note 34, at 342-43 (noting that in 19 
appeals of inter partes reexamination to the Federal Circuit,  the court dismissed 14 and 
affirmed 5). 
  
Appendix A: IPR Data by NPE Status and Tech Classification 
 
 Overall NPEs Prod. Cos.  High Tech Bio./Pharma./Chem.  Med. Device/Mech.  Other 
Share of all IPRs (no.): 100% (979) 48.3% (473) 51.7% (506) 67.1% (657) 11.3% (111) 18.2% (178) 3.4% (33) 
Institution rate (no.): 84.0% (691/823) 88.7% (331/373)    80% (360/450)* 83.8% (462/551) 83.2% (79/95) 82.6% (123/149) 96.4% (27/28) 
Among instituted IPRs, 
share instituting all 
challenged claims (no.) 
74.0% (511/691) 77.0% (255/331) 71.1% (256/360) 73.4% (339/462) 74.7% (59/79) 75.6% (93/123) 74.1% (20/27) 
Among instituted IPRs, 
share of claims 
instituted (no.) 
88.3% (9769/11059) 90.8% (4559/5020) 86.3% (5210/6039)* 86.5% (6339/7325) 90.2% (1185/1313) 92.9% (1742/1875) 92.1% (503/546) 
Among IPRs with 
decision on the merits, 
share invalidating all 
instituted claims (no.) 
77.5% (124/160) 75.3% (64/84) 78.1% (60/76) 72% (72/100) 87.0% (20/23) 93.1% (27/29) 62.5% (5/8) 
Stay rate in suits co-
pending instituted IPRs 
(no. suits w/ a decided 
motion) 
81.9% (171) 85.5% (90) 77.8% (81) 
 
* p <  0.01 
82.9% (105) 58.3% (12) 85.7% (42) 83.3% (12) 
 
 
  
Appendix B: IPX vs. IPR 
 
 Inter Partes 
Reexamination 
Inter Partes  
Review 
Total Petitions, as of Sept.  30, 
2014: 
1919 1841 
Petitions per Month: 12.5 75.1 
Average Duration to Final Decision 
(months) 
36.0 14.9 
Tech Breakdown: 
    Electrical: 
    Chemical: 
    Mechanical: 
 
45.1% 
14.9% 
25.5% 
 
67.1% 
11.3% 
18.2% 
Institution Rate 93.4% 84.0% 
All (Instituted) Claims Invalidated 31.5% 78.8% 
Amended Claims Added 60.9% 0.62% 
Percent with Co-Pending Litigation 75.5% 78.8% 
Grant Rate for Motions to Stay ~50% 81.9% 
 
 
